{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:54:46Z","timestamp":1793044486295,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG3D0141"],"award-info":[{"award-number":["CIRPG3D0141"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG3F0021"],"award-info":[{"award-number":["CIRPG3F0021"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CIRPG3F0022"],"award-info":[{"award-number":["CIRPG3F0022"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taiwan Ministry of Science and Technology","award":["MOST 106-2627-M-182A-001"],"award-info":[{"award-number":["MOST 106-2627-M-182A-001"]}]},{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30 CA16672"],"award-info":[{"award-number":["P30 CA16672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijrobp.2019.02.032","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T21:52:24Z","timestamp":1550785944000},"page":"73-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy"],"prefix":"10.1016","volume":"105","author":[{"given":"Cheng-En","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu Prasad","family":"Venkatesulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hsin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Ping","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Fong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik Panambur","family":"Aithala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tung-Chieh Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan-Ming","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chieh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Hwei","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chi","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.02.032_bib1","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5009\/gnl15257","article-title":"Epidemiology of hepatocellular carcinoma in the Asia-Pacific region","volume":"10","author":"Zhu","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000449343","article-title":"Hepatocellular carcinoma: Therapeutic guidelines and medical treatment","volume":"6","author":"Kudo","year":"2016","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2015.02.010","article-title":"Transarterial chemoembolization: Modalities, indication, and patient selection","volume":"62","author":"Sieghart","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib8","first-page":"CD004787","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.02.001","article-title":"Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review","volume":"111","author":"Dionisi","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semradonc.2011.05.007","article-title":"Charged-Particle Therapy for Hepatocellular Carcinoma","volume":"21","author":"Skinner","year":"2011","journal-title":"Seminars in Radiation Oncology"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib13","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/cncr.25809","article-title":"The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial","volume":"117","author":"Bush","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2010.07.015","article-title":"Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols","volume":"81","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib15","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1002\/cncr.26134","article-title":"Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma","volume":"117","author":"Komatsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib16","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1002\/cncr.24619","article-title":"Proton beam therapy for hepatocellular carcinoma: The University of Tsukuba experience","volume":"115","author":"Nakayama","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib17","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1158\/1078-0432.CCR-04-1350","article-title":"Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients","volume":"11","author":"Chiba","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00066-014-0604-6","article-title":"Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"190","author":"Lee","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib20","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jlts.2002.31654","article-title":"Body surface area and body weight predict total liver volume in Western adults","volume":"8","author":"Vauthey","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.radonc.2007.12.009","article-title":"4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning","volume":"87","author":"Beddar","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijrobp.2008.04.054","article-title":"Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration method","volume":"72","author":"Wang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib25","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.ijrobp.2011.05.056","article-title":"Evaluation of liver function after proton beam therapy for hepatocellular carcinoma","volume":"82","author":"Mizumoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-8-48","article-title":"What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy","volume":"8","author":"Toramatsu","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib28","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.ijrobp.2018.06.329","article-title":"Predictors of Radiation-Induced Liver Disease in Patients with Hepatocellular Carcinoma Undergoing Proton Beam Therapy","volume":"102","author":"Hsieh","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib29","doi-asserted-by":"crossref","first-page":"e0203854","DOI":"10.1371\/journal.pone.0203854","article-title":"How small is TOO small? New liver constraint is needed\u2013 Proton therapy of hepatocellular carcinoma patients with small normal live","volume":"13","author":"Lee","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib30","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois","year":"1989","journal-title":"Nutrition"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib32","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2004.12.031","article-title":"Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease","volume":"62","author":"Cheng","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ijrobp.2009.12.048","article-title":"Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma","volume":"79","author":"Kawashima","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib36","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1748-717X-8-249","article-title":"Radiation-induced liver disease after\u00a0stereotactic body radiotherapy for small hepatocellular carcinoma: Clinical and dose-volumetric parameters","volume":"8","author":"Jung","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1089253217699888","article-title":"Small-for-size syndrome: Bridging the gap between liver transplantation and graft recovery","volume":"21","author":"Rajakumar","year":"2017","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib39","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/01.sla.0000098618.11382.77","article-title":"Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation","volume":"238","author":"Fan","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1072-7515(01)00800-6","article-title":"Small-for-size grafts in living-related liver transplantation. No competing interests declared","volume":"192","author":"Sugawara","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000335713","article-title":"How much remnant is enough in liver resection?","volume":"29","author":"Guglielmi","year":"2012","journal-title":"Dig Surg"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00534-004-0965-9","article-title":"Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test","volume":"12","author":"Imamura","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.radonc.2013.01.016","article-title":"Feasibility study of in\u00a0vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients","volume":"106","author":"Yuan","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib44","doi-asserted-by":"crossref","first-page":"e0167155","DOI":"10.1371\/journal.pone.0167155","article-title":"Evaluation of focal liver reaction after proton beam therapy for hepatocellular carcinoma examined using Gd-EOB-DTPA enhanced hepatic magnetic resonance imaging","volume":"11","author":"Takamatsu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semradonc.2005.04.005","article-title":"Partial volume tolerance of the liver to radiation","volume":"15","author":"Dawson","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: A concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib47","doi-asserted-by":"crossref","first-page":"e77472","DOI":"10.1371\/journal.pone.0077472","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: Prognostic factors of local control, overall survival, and toxicity","volume":"8","author":"Bibault","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib48","doi-asserted-by":"crossref","first-page":"20130147","DOI":"10.1259\/bjr.20130147","article-title":"Determination and comparison of radiotherapy dose responses for hepatocellular carcinoma and metastatic colorectal liver tumours","volume":"86","author":"Lausch","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1748-717X-8-250","article-title":"High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma","volume":"8","author":"Jang","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib50","doi-asserted-by":"crossref","first-page":"W153","DOI":"10.2214\/AJR.07.2181","article-title":"Liver volume variation in patients with virus-induced cirrhosis: Findings on MDCT","volume":"189","author":"Zhou","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10620-014-3038-1","article-title":"Liver volume in the cirrhotic patient: Does size matter?","volume":"59","author":"Hagan","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijrobp.2019.02.032_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11684-012-0223-5","article-title":"Assessment of liver volume variation to evaluate liver function","volume":"6","author":"Tong","year":"2012","journal-title":"Front Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619302640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619302640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:45:11Z","timestamp":1759743911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619302640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0360301619302640"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.032","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}